Ubs Group Ag Spring Works Therapeutics, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 134,679 shares of SWTX stock, worth $4.79 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

134,679

Previous 135,604 0.68%

Holding current value

$4.79 Million

Previous $5.11 Million 15.52%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$32.04 - $42.76 $29,637 - $39,553	-925 Reduced 0.68%	134,679 $4.32 Million
Q2 2024 Aug 13, 2024	SELL	$36.06 - $47.62 $2.81 Million - $3.71 Million	-77,929 Reduced 36.5%	135,604 $5.11 Million
Q1 2024 May 13, 2024	BUY	$36.5 - $52.5 $2.7 Million - $3.88 Million	73,861 Added 52.88%	213,533 $10.5 Million
Q4 2023 Feb 09, 2024	BUY	$18.94 - $37.24 $2.06 Million - $4.06 Million	108,966 Added 354.87%	139,672 $5.1 Million
Q3 2023 Nov 09, 2023	SELL	$23.12 - $31.38 $1.23 Million - $1.67 Million	-53,229 Reduced 63.42%	30,706 $709,000
Q2 2023 Aug 11, 2023	SELL	$23.15 - $32.71 $54,194 - $76,574	-2,341 Reduced 2.71%	83,935 $2.2 Million
Q1 2023 May 12, 2023	SELL	$24.97 - $34.05 $1.57 Million - $2.14 Million	-62,840 Reduced 42.14%	86,276 $2.22 Million
Q4 2022 Feb 08, 2023	BUY	$21.73 - $28.72 $2.18 Million - $2.88 Million	100,204 Added 204.87%	149,116 $3.88 Million
Q3 2022 Nov 10, 2022	SELL	$24.1 - $39.66 $796,143 - $1.31 Million	-33,035 Reduced 40.31%	48,912 $1.4 Million
Q2 2022 Aug 10, 2022	SELL	$18.36 - $60.07 $35,930 - $117,556	-1,957 Reduced 2.33%	81,947 $2.02 Million
Q1 2022 May 16, 2022	BUY	$48.97 - $65.46 $2.89 Million - $3.86 Million	58,991 Added 236.79%	83,904 $4.74 Million
Q4 2021 Feb 14, 2022	SELL	$53.3 - $75.84 $961,905 - $1.37 Million	-18,047 Reduced 42.01%	24,913 $1.54 Million
Q3 2021 Nov 15, 2021	BUY	$62.66 - $88.26 $2.54 Million - $3.57 Million	40,485 Added 1635.76%	42,960 $2.73 Million
Q2 2021 Aug 13, 2021	SELL	$67.45 - $85.63 $2.94 Million - $3.74 Million	-43,633 Reduced 94.63%	2,475 $204,000
Q1 2021 May 12, 2021	BUY	$65.1 - $93.59 $2.87 Million - $4.13 Million	44,091 Added 2185.97%	46,108 $3.39 Million
Q4 2020 Feb 11, 2021	BUY	$48.36 - $77.92 $74,522 - $120,074	1,541 Added 323.74%	2,017 $147,000
Q3 2020 Nov 12, 2020	BUY	$36.14 - $51.99 $17,202 - $24,747	476 New	476 $23,000
Q2 2020 Jul 31, 2020	SELL	$22.98 - $48.57 $8,916 - $18,845	-388 Closed	0 $0
Q1 2020 May 01, 2020	SELL	$20.44 - $41.21 $39,898 - $80,441	-1,952 Reduced 83.42%	388 $10,000
Q4 2019 Feb 14, 2020	SELL	$17.74 - $39.52 $70 - $158	-4 Reduced 0.17%	2,340 $90,000
Q3 2019 Nov 14, 2019	BUY	$18.8 - $27.82 $44,067 - $65,210	2,344 New	2,344 $51,000

Others Institutions Holding SWTX

# of Institutions

237

Shares Held

68.9M

Call Options Held

144K

Put Options Held

257K

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.22B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account